IMMUNOTHERAPY IN HEAD AND NECK CANCER: ADVANCES IN IMMUNE CHECKPOINT INHIBITION AND TARGETED IMMUNOTHERAPIES FOR ENHANCED TREATMENT OUTCOMES. Med. Ins. J. 2024;2(02):11-20. Accessed May 9, 2026. https://medicalinsights.online/index.php/journal/article/view/26